← Leaderboards
Kipp A Weiskopf
Stanford University
$1,458,026
Attributed
$1,458,026
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $446.1K · FY2012–25$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,458,026 · 2
By mechanism
R01$1,315,886 · 1
F30$142,140 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Samuel Strober$36,157,957
- Edgar G. Engleman$35,389,843
- Irving Lerner Weissman$56,491,773
- Olivia M Martinez$20,491,021
- Robert S Negrin$29,816,136
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelSuccessImmune SystemMalignant NeoplasmsPtpns1 GeneSolid NeoplasmCellsImmuneIn VitroMacrophageMutantPre-Clinical ModelReceptorSignal TransductionBlocking AntibodiesCancer CellEatingEngraftmentCancer TherapyCancer TypeIn VivoCd47 GeneAntibodiesSurface
Grant awards (6)
KRAS inhibitors prime cancer cells for macrophage-mediated destruction$446,063
R01 · FY2025 · CA · contact PI
KRAS inhibitors prime cancer cells for macrophage-mediated destruction$423,760
R01 · FY2024 · CA · contact PI
KRAS inhibitors prime cancer cells for macrophage-mediated destruction$446,063
R01 · FY2023 · CA · contact PI
EVOLVING HIGH AFFINITY SIRPa MUTANTS TO STIMULATE PHAGOCYTOSIS OF TUMOR CELLS$47,676
F30 · FY2014 · CA · contact PI
EVOLVING HIGH AFFINITY SIRPa MUTANTS TO STIMULATE PHAGOCYTOSIS OF TUMOR CELLS$47,232
F30 · FY2013 · CA · contact PI
EVOLVING HIGH AFFINITY SIRPa MUTANTS TO STIMULATE PHAGOCYTOSIS OF TUMOR CELLS$47,232
F30 · FY2012 · CA · contact PI